This site places cookies on your device to offer you a better browsing experience. You can visit this page to find out more on how we use cookies and how you can change your settings. If you continue browsing our site, we’ll assume you agree to our cookie use.      Accept this cookie | Find out more

Țuca Zbârcea & Asociații
Print Site Map
   
Home/News
News
 
 
 
News
Event: GDPR – six months after its entry into force. Still hard to put in practice? On November 15th, at the Intercontinental Hotel, Fortuna Hall, will be held the conference “GDPR - Hard to Put in Practice?”. The event is hosted by Tuca Zbarcea & Asociatii and will have an interactive character, sprinkled with actual examples. The conference is mainly addressed to legal counsellors and data protection officers, human resources managers, marketing directors, and internal audit and information technology specialists. On November 15th, at the Intercontinental Hotel, Fortuna Hall, will be held the conference “GDPR - Hard to Put in Practice?”. The event is hosted by Tuca Zbarcea & Asociatii and will have an interactive character, sprinkled with actual examples. The conference is mainly addressed to legal counsellors and data protection officers, human resources managers, marketing directors, and internal audit and information technology specialists. Lectures will be given by lawyers from Tuca Zbarcea & Asociatii specialising in data protection and IT specialists from iSec Associates (member of ProVision IT Group), as well as Power Net Consulting, with extensive experience in ensuring security and data integrity. Also, representatives from The National Supervisory Authority For Personal Data Processing will be present at the event. According to the organisers, “through the GDPR - Hard to Put in Practice? conference, we aim to focus the experience gained by our specialists in coordinating and implementing GDPR compliance projects in the most diverse industries, from finance to telecom, creative industries, media or direct marketing. Thus, we will bring to the audience, from the GDPR “tranches”, a series of challenges and difficulties, practical solutions as well as grey areas that still require clarification or crystallisation based on secondary regulations, guidelines and the practice of ANSPDCP and other supervisory authorities.” The discussion topics will address the following issues: / Marketing vs. GDPR / LIAnt for legitimate interest / Disclosure of data at the request of public authorities / Operator or empowered person? A complicated casting / Employee monitoring. Same dilemmas, new challenges / Security of personal data - practical aspects / CASE STUDY Virtual world. Concrete risks or How to build a website fully compliant with GDPR? Further details on the registration procedure, the participation fee and the full program of the event can be found here: http://dataprivacyblog.tuca.ro/conferinta-bilant-la-6-luni-de-la-intrarea-in-vigoare-a-regulamentului-ue-nr-6792016-gdpr/
October 30, 2018
Event: GDPR – six months after its entry into force. Still hard to put in practice?
On November 15th, at the Intercontinental Hotel, Fortuna Hall, will be held the conference “GDPR - Hard to Put in Practice?”. The event is hosted by Țuca Zbârcea & Asociații and will have an interactive character, sprinkled with actual examples. The conference is mainly addressed to legal counsellors and data protection officers, human resources managers, marketing directors, and internal audit and information technology specialists. [+]

On November 15th, at the Intercontinental Hotel, Fortuna Hall, will be held the conference “GDPR - Hard to Put in Practice?”. The event is hosted by Țuca Zbârcea & Asociații and will have an interactive character, sprinkled with actual examples. The conference is mainly addressed to legal counsellors and data protection officers, human resources managers, marketing directors, and internal audit and information technology specialists.

Lectures will be given by lawyers from Țuca Zbârcea & Asociații specialising in data protection and IT specialists from iSec Associates (member of ProVision IT Group), as well as Power Net Consulting, with extensive experience in ensuring security and data integrity. Also, representatives from The National Supervisory Authority For Personal Data Processing will be present at the event.

According to the organisers, “through the GDPR - Hard to Put in Practice? conference, we aim to focus the experience gained by our specialists in coordinating and implementing GDPR compliance projects in the most diverse industries, from finance to telecom, creative industries, media or direct marketing. Thus, we will bring to the audience, from the GDPR “tranches”, a series of challenges and difficulties, practical solutions as well as grey areas that still require clarification or crystallisation based on secondary regulations, guidelines and the practice of ANSPDCP and other supervisory authorities.”

The discussion topics will address the following issues:
/ Marketing vs. GDPR
/ LIAnt for legitimate interest
/ Disclosure of data at the request of public authorities
/ Operator or empowered person? A complicated casting
/ Employee monitoring. Same dilemmas, new challenges
/ Security of personal data - practical aspects
/ CASE STUDY Virtual world. Concrete risks or How to build a website fully compliant with GDPR?

Further details on the registration procedure, the participation fee and the full program of the event can be found here: http://dataprivacyblog.tuca.ro/conferinta-bilant-la-6-luni-de-la-intrarea-in-vigoare-a-regulamentului-ue-nr-6792016-gdpr/  

[-]

Tuca Zbarcea & Asociatii acts for Sanofi in €1.9 billion pharma deal Sanofi and Advent International have announced the completion of the deal under which Advent International purchased Zentiva, Sanofi’s European generics business for €1.9 billion. Tuca Zbarcea & Asociatii acted for Sanofi, with Bucharest M&A partner Sorin Vladescu and Capital markets partner Silvana Ivan-Hanganu at the helm of the team. They advised on the Romanian legal aspects incident to the transaction, including various corporate, commercial, M&A issues, as well as assisted in the structuring of the transaction from capital markets perspective (considering that Zentiva S.A. Romania is a company listed on the stock exchange). Sanofi and Advent International have announced the completion of the deal under which Advent International purchased Zentiva, Sanofi’s European generics business for €1.9 billion. According to a press release issued on Monday, Advent will support the Zentiva management team to invest in the company’s operations, production facilities and R&D pipeline. The deal was announced in April 2018 and was subject to finalisation of definitive agreements, completion of the appropriate social processes and approval of relevant regulatory authorities. Tuca Zbarcea & Asociatii acted for Sanofi, with Bucharest M&A partner Sorin Vladescu and Capital markets partner Silvana Ivan-Hanganu at the helm of the team. They advised on the Romanian legal aspects incident to the transaction, including various corporate, commercial, M&A issues, as well as assisted in the structuring of the transaction from capital markets perspective (considering that Zentiva S.A. Romania is a company listed on the stock exchange). Advent is a global investor, with over 25 years’ experience of investing in the healthcare sector. It has extensive experience of executing corporate carve-outs and leveraging this expertise will support Zentiva as it enters a new phase of its history as an independent business. Headquartered in Prague, Zentiva reaches over 40 million patients in 25 European countries, including Romania, being one of the largest generics players in Europe. (According to the information provided by https://www.adventinternational.com/advent-international-completed-acquisition-of-zentiva-from-sanofi/ and https://www.adventinternational.com/advent-international-enters-exclusive-negotiations-acquire-zentiva-sanofis-european-generics-business/)
October 2, 2018
Țuca Zbârcea & Asociații acts for Sanofi in €1.9 billion pharma deal

Sanofi and Advent International have announced the completion of the deal under which Advent International purchased Zentiva, Sanofi’s European generics business for €1.9 billion.

Țuca Zbârcea & Asociații acted for Sanofi, with Bucharest M&A partner Sorin Vlădescu and Capital markets partner Silvana Ivan-Hanganu at the helm of the team. They advised on the Romanian legal aspects incident to the transaction, including various corporate, commercial, M&A issues, as well as assisted in the structuring of the transaction from capital markets perspective (considering that Zentiva S.A. Romania is a company listed on the stock exchange). [+]

Sanofi and Advent International have announced the completion of the deal under which Advent International purchased Zentiva, Sanofi’s European generics business for €1.9 billion.

According to a press release issued on Monday, Advent will support the Zentiva management team to invest in the company’s operations, production facilities and R&D pipeline. The deal was announced in April 2018 and was subject to finalisation of definitive agreements, completion of the appropriate social processes and approval of relevant regulatory authorities.

Țuca Zbârcea & Asociații acted for Sanofi, with Bucharest M&A partner Sorin Vlădescu and Capital markets partner Silvana Ivan-Hanganu at the helm of the team. They advised on the Romanian legal aspects incident to the transaction, including various corporate, commercial, M&A issues, as well as assisted in the structuring of the transaction from capital markets perspective (considering that Zentiva S.A. Romania is a company listed on the stock exchange). 

Advent is a global investor, with over 25 years’ experience of investing in the healthcare sector. It has extensive experience of executing corporate carve-outs and leveraging this expertise will support Zentiva as it enters a new phase of its history as an independent business.

Headquartered in Prague, Zentiva reaches over 40 million patients in 25 European countries, including Romania, being one of the largest generics players in Europe.

(According to the information provided by https://www.adventinternational.com/advent-international-completed-acquisition-of-zentiva-from-sanofi/ and https://www.adventinternational.com/advent-international-enters-exclusive-negotiations-acquire-zentiva-sanofis-european-generics-business/)

[-]

News Archive

Back to News
Get all the news using the RSS Feeds
Get all the news using the RSS Feeds rss



March-April 2019
Print Quality Download
Fast-Web Quality Download
pdf file
Read more



Țuca Zbârcea & Asociații and Țuca Zbârcea & Asociații Tax are collaborating with Andersen Global in Romania
Copyright © 2007 - 2019 Țuca Zbârcea & Asociații
Privacy Policy | Terms and Conditions